Industrial Biotechnology Corp.; Rated 'Speculative Buy,' Target Price $2.20 By Beacon Equity Research
Posted on: Monday, 4 August 2008, 09:00 CDT
Industrial Biotechnology Corp. (Pink Sheets: IBOT) has been rated Speculative Buy with a price target of $2.20 by Beacon Analyst, Victor Sula, Ph.D.
The full report is available at http://www.beaconequity.com/adpages/IBOT.
Anyone interested in receiving alerts regarding IBOT research should e-mail members@beaconequity.com with "IBOT" in the subject line.
In the report, the analyst writes, "... based on our understanding of IBOT's business model and our discussions with management, we believe the Company has a good chance of becoming a rising star in the U.S. biofuel market ... IBOT has formed a strategic alliance with Cosan SA, to provide ethanol for the Company's Renewable Fuels of America Inc. and Renewable Chemicals Corp. subsidiaries ... and plans to commence shipments of sugar cane ethanol into the U.S. market in late 2008 or early 2009."
Other companies in the alternative energy sector include: Pacific Ethanol Inc. (Nasdaq: PEIX), Verasun Energy Corp. (NYSE: VSE), Aventine Renewable Energy (NYSE: AVR) and Archer-Daniels-Midland Co. (NYSE: ADM).
Beacon Equity Research Disclosure
The analysts contributing to this report do not hold any shares of IBOT. Additionally the analysts contributing to this report certify that the views expressed herein accurately reflect the analysts' personal views as to the subject securities and issuers. The analyst(s) writing this report recognize and aspire to all of the CFA Institute Guidelines for Independent Research. Beacon Equity Research ("Beacon") certifies that no part of the analysts' compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analysts in the report.
BER and its affiliates have been compensated twenty three thousand dollars a month from Rovert Consulting for enrollment of IBOT in its research program and other services. This report is based on data obtained from sources we believe to be reliable, but is not guaranteed as to accuracy and does not purport to be complete. As such, the report should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed herein are subject to change.
Source: Business Wire
Related Articles
- IBM Receives SMB Excellence Award From Major Industry Analyst Firm For Express Advantage
- Lexmark to Host Securities Analyst Meeting March 26 at NYSE
- Analyst Actions: American Express, Linear Technology, eBay, Jones Apparel
- Chemokine Therapeutics Receives Approval From Hong Kong to Commence Phase II Study in Liver Cancer and Fundamental Research Corporation Initiates Analyst Coverage
- Zacks Analyst Interview Highlights: Arch Coal, Peabody Energy, Consol, Penn Virginia and Natural Resource Partners
- New Research From Leading Analyst Firm Recommends Network Behavior Analysis for Optimizing Network Performance
- QualityStocks Announces Release of an Independent Analyst Report for ALL Fuels &Amp; Energy Company -- Target Price Set at $3.40
- Zacks All Star Analysts Portfolio Highlights: Diamond Offshore, Helix Energy, Marriott Int'L and Rowan Cos.
- Zacks Analyst Interview Highlights: Arch Coal, Peabody Energy and CONSOL Energy
- Hydrogen Power, ISE-CCM Index Performers Poised To Grow, With US Oil Vulnerable To Supply Disruptions And Price Spikes, Says Investrend Analyst Piyali Chakravarty In Q3 Alternative Energy Sector Report
 |
 |
User Comments (0)
RSS Feeds